EcoDrugPlus

Map Kinase-Activated Protein Kinase 5

Ensembl ID : ENSSTUG00000028588
Gene Symbol: LOC115164960
3 Cross references
174 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSSTUG00000005779
Gene Symbol: LOC115157656
3 Cross references
155 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSSTUG00000043323
Gene Symbol: LOC115158335
3 Cross references
202 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSSTUG00000023091
Gene Symbol: LOC115192546
3 Cross references
202 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSSTUG00000036499
Gene Symbol: MAPKAPK2
3 Cross references
187 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSSTUG00000039455
Gene Symbol: MCL1B
1 Cross references
212 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSSTUG00000039379
Gene Symbol: MCL1B
1 Cross references
212 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSSTUG00000004762
Gene Symbol: MLST8
1 Cross references
147 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSSTUG00000001202
Gene Symbol: LOC115202547
3 Cross references
152 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSSTUG00000034192
Gene Symbol: LOC115166706
3 Cross references
152 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSSTUG00000007984
Gene Symbol: NQO1
3 Cross references
163 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSSTUG00000023727
Gene Symbol: NPC1L1
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).